Nf Kappab is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Nf Kappab is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
NF-kappaB (NF-κB) is a family of transcription factors that regulates genes involved in inflammation, cell survival, proliferation, and immune responses. In the central nervous system, [NF-κB](/entities/nf-kb) plays dual roles—physiologically regulating neuronal function and pathologically driving neuroinflammation in neurodegenerative diseases[@karin2002].
Family Members
The NF-κB family consists of five related proteins:
p65 (RelA): Transactivation domain, primarily in [neurons](/entities/neurons)
p50 (NFKB1): Generated from p105 precursor
p52 (NFKB2): Generated from p100 precursor
c-Rel: Lymphoid-restricted
RelB: Dendritic cell function
These form various homodimers and heterodimers with distinct functions.
Signaling Pathways
Classical (Canonical) Pathway
Activated by TNF-α, IL-1β, LPS, pathogens
IKK complex phosphorylates IκBα
IκBα degradation releases p65/p50 dimer
Rapid nuclear translocation
Alternative (Non-canonical) Pathway
Activated by lymphotoxin, BAFF, CD40
NIK activates IKKα
p100 processing to p52
RelB/p52 dimers translocate
Normal Physiological Functions
Neuronal Function
NF-κB regulates essential neuronal genes:
Synaptic plasticity genes
Anti-apoptotic proteins (Bcl-2, Bcl-xL)
Neurotrophic factors
Immediate early genes (c-Fos, c-Jun)[@kaltschmidt2009]
Glial Function
In [microglia](/cell-types/microglia-neuroinflammation) and [astrocytes](/entities/astrocytes):
Karin M, Lin A. (2002). NF-kappaB at the crossroads of life and death. Nat Immunol 3(3):221-227.
Kaltschmidt B, et al. (2005). NF-kappaB in the nervous system. Cold Spring Harb Perspect Biol 1(3):a001271.
Chen CH, et al. (2012). NF-κB as a therapeutic target in neurodegenerative diseases. Expert Opin Ther Targets 16(8):805-828.
Hunot S, et al. (2004). Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with Parkinson disease. Proc Natl Acad Sci U S A 101(1):101-106.
Swarup V, et al. (2011). NF-κB in the pathogenesis and treatment of ALS. Mol Neurobiol 44(1):43-51.
The study of Nf Kappab has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Karin M, Lin A, NF-kappaB at the crossroads of life and death (2002)](https://pubmed.ncbi.nlm.nih.gov/11850721/)
[Kaltschmidt B, Kaltschmidt C, NF-kappaB in the nervous system (2009)](https://pubmed.ncbi.nlm.nih.gov/20066083/)
[Chen CH, Zhou W, Liu S, NF-κB as a therapeutic target in neurodegenerative diseases (2012)](https://pubmed.ncbi.nlm.nih.gov/22775423/)
[Hunot S, Vila M, Teismann P, et al, Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with Parkinson disease (2004)](https://pubmed.ncbi.nlm.nih.gov/14695885/)
[Swarup V, Phaneuf D, Dupré N, et al, Deregulation of TDP-43 in the pathogenesis of Amyotrophic Lateral Sclerosis (2011)](https://pubmed.ncbi.nlm.nih.gov/22143420/)
Pathway Diagram
The following diagram shows the key molecular relationships involving NF-kappaB discovered through SciDEX knowledge graph analysis: